These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
591 related articles for article (PubMed ID: 29060925)
1. Breath based volatile organic compounds in the detection of breast, lung, and colorectal cancers: A systematic review. Oakley-Girvan I; Davis SW Cancer Biomark; 2017 Dec; 21(1):29-39. PubMed ID: 29060925 [TBL] [Abstract][Full Text] [Related]
2. The analysis of volatile organic compounds biomarkers for lung cancer in exhaled breath, tissues and cell lines. Wang Y; Hu Y; Wang D; Yu K; Wang L; Zou Y; Zhao C; Zhang X; Wang P; Ying K Cancer Biomark; 2012; 11(4):129-37. PubMed ID: 23144150 [TBL] [Abstract][Full Text] [Related]
3. Effects of Curative Colorectal Cancer Surgery on Exhaled Volatile Organic Compounds and Potential Implications in Clinical Follow-up. Altomare DF; Di Lena M; Porcelli F; Travaglio E; Longobardi F; Tutino M; Depalma N; Tedesco G; Sardaro A; Memeo R; de Gennaro G Ann Surg; 2015 Nov; 262(5):862-6; discussion 866-7. PubMed ID: 26583677 [TBL] [Abstract][Full Text] [Related]
4. Exhaled VOC detection in lung cancer screening: a comprehensive meta-analysis. Fan X; Zhong R; Liang H; Zhong Q; Huang H; He J; Chen Y; Wang Z; Xie S; Jiang Y; Lin Y; Chen S; Liang W; He J BMC Cancer; 2024 Jun; 24(1):775. PubMed ID: 38937687 [TBL] [Abstract][Full Text] [Related]
5. Detection of volatile organic compounds in exhaled breath to screen lung cancer: a systematic review. Hua Q; Zhu Y; Liu H Future Oncol; 2018 Jul; 14(16):1647-1662. PubMed ID: 29939068 [TBL] [Abstract][Full Text] [Related]
6. Relationship between cancer tissue derived and exhaled volatile organic compound from colorectal cancer patients. Preliminary results. De Vietro N; Aresta A; Rotelli MT; Zambonin C; Lippolis C; Picciariello A; Altomare DF J Pharm Biomed Anal; 2020 Feb; 180():113055. PubMed ID: 31877489 [TBL] [Abstract][Full Text] [Related]
7. Real-time ultrasensitive VUV-PIMS detection of representative endogenous volatile markers in cancers. Li Z; Shu J; Zhang P; Sun W; Yang B; Zhang H Cancer Biomark; 2016; 16(3):477-87. PubMed ID: 27062705 [TBL] [Abstract][Full Text] [Related]
8. Analysis of volatile organic compounds in the breath of patients with stable or acute exacerbation of chronic obstructive pulmonary disease. Pizzini A; Filipiak W; Wille J; Ager C; Wiesenhofer H; Kubinec R; Blaško J; Tschurtschenthaler C; Mayhew CA; Weiss G; Bellmann-Weiler R J Breath Res; 2018 Mar; 12(3):036002. PubMed ID: 29295966 [TBL] [Abstract][Full Text] [Related]
9. Exhaled breath and urinary volatile organic compounds (VOCs) for cancer diagnoses, and microbial-related VOC metabolic pathway analysis: a systematic review and meta-analysis. Zhou M; Wang Q; Lu X; Zhang P; Yang R; Chen Y; Xia J; Chen D Int J Surg; 2024 Mar; 110(3):1755-1769. PubMed ID: 38484261 [TBL] [Abstract][Full Text] [Related]
10. Volatile signature for the early diagnosis of lung cancer. Gasparri R; Santonico M; Valentini C; Sedda G; Borri A; Petrella F; Maisonneuve P; Pennazza G; D'Amico A; Di Natale C; Paolesse R; Spaggiari L J Breath Res; 2016 Feb; 10(1):016007. PubMed ID: 26857451 [TBL] [Abstract][Full Text] [Related]
11. Volatile organic compounds (VOCs) in exhaled breath of patients with breast cancer in a clinical setting. Mangler M; Freitag C; Lanowska M; Staeck O; Schneider A; Speiser D Ginekol Pol; 2012 Oct; 83(10):730-6. PubMed ID: 23383557 [TBL] [Abstract][Full Text] [Related]
12. Confounding effect of benign pulmonary diseases in selecting volatile organic compounds as markers of lung cancer. Wang M; Sheng J; Wu Q; Zou Y; Hu Y; Ying K; Wan H; Wang P J Breath Res; 2018 Sep; 12(4):046013. PubMed ID: 30102249 [TBL] [Abstract][Full Text] [Related]
13. Diagnosis by Volatile Organic Compounds in Exhaled Breath from Lung Cancer Patients Using Support Vector Machine Algorithm. Sakumura Y; Koyama Y; Tokutake H; Hida T; Sato K; Itoh T; Akamatsu T; Shin W Sensors (Basel); 2017 Feb; 17(2):. PubMed ID: 28165388 [TBL] [Abstract][Full Text] [Related]
14. Association of Smoking with Metabolic Volatile Organic Compounds in Exhaled Breath. Chen X; Wang F; Lin L; Dong H; Huang F; Ghulam Muhammad K; Chen L; Gorlova OY Int J Mol Sci; 2017 Oct; 18(11):. PubMed ID: 29068415 [TBL] [Abstract][Full Text] [Related]
15. Detection of lung, breast, colorectal, and prostate cancers from exhaled breath using a single array of nanosensors. Peng G; Hakim M; Broza YY; Billan S; Abdah-Bortnyak R; Kuten A; Tisch U; Haick H Br J Cancer; 2010 Aug; 103(4):542-51. PubMed ID: 20648015 [TBL] [Abstract][Full Text] [Related]
16. Volatile organic compounds in breath can serve as a non-invasive diagnostic biomarker for the detection of advanced adenomas and colorectal cancer. van Keulen KE; Jansen ME; Schrauwen RWM; Kolkman JJ; Siersema PD Aliment Pharmacol Ther; 2020 Feb; 51(3):334-346. PubMed ID: 31858615 [TBL] [Abstract][Full Text] [Related]
17. Review of recent developments in determining volatile organic compounds in exhaled breath as biomarkers for lung cancer diagnosis. Zhou J; Huang ZA; Kumar U; Chen DDY Anal Chim Acta; 2017 Dec; 996():1-9. PubMed ID: 29137702 [TBL] [Abstract][Full Text] [Related]
18. Quantitative breath analysis of volatile organic compounds of lung cancer patients. Song G; Qin T; Liu H; Xu GB; Pan YY; Xiong FX; Gu KS; Sun GP; Chen ZD Lung Cancer; 2010 Feb; 67(2):227-31. PubMed ID: 19409642 [TBL] [Abstract][Full Text] [Related]
19. Blinded Validation of Breath Biomarkers of Lung Cancer, a Potential Ancillary to Chest CT Screening. Phillips M; Bauer TL; Cataneo RN; Lebauer C; Mundada M; Pass HI; Ramakrishna N; Rom WN; Vallières E PLoS One; 2015; 10(12):e0142484. PubMed ID: 26698306 [TBL] [Abstract][Full Text] [Related]
20. Noninvasive detection of colorectal cancer by analysis of exhaled breath. Wang C; Ke C; Wang X; Chi C; Guo L; Luo S; Guo Z; Xu G; Zhang F; Li E Anal Bioanal Chem; 2014 Jul; 406(19):4757-63. PubMed ID: 24820062 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]